These 3 tidbits from the recent 8K are some of the reason that I invest in AMIC. Perhaps AMIC doesn't know how to pursue FDA (re)classification, but we have a much better chance with Battelle picking up after AMIC dropped the ball.
1) ........ in the principal amount of $349,913.41 as payment for research services performed by Battelle for the Company. 2) " ......... We continue our close collaboration with Battelle and look forward to commercializing this exciting technology.” 3) Battelle acquired its interest in AMIC by converting a note previously issued for partial consideration of studies conducted at PNNL..... MDLAND~
SS and medplay01, I'm fresh out of dry powder right now, but you guys make a compelling argument for ADMD and RadioGel, such that I may have to take a look at my portfolio this week and shift some funds. As I mentioned weeks back when Battelle first filed, my ears perked up bigtime when I read the news and saw 10% (plus) ownership. At $.02, this seems to be a bargain. Let me hash over my DD and get back to you guys. MDLAND~